Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Walter G Land"'
Autor:
Walter G. Land
Publikováno v:
Frontiers in Transplantation, Vol 3 (2024)
Walter Brendel was a physiologist who headed the Institut of Experimental Surgery at the University of Munich (LMU) from 1961 until 1989. His legendary career began with the development of an anti-human lymphocyte globulin (ALG) at his Institute duri
Externí odkaz:
https://doaj.org/article/71283240149b49b6916ed2dec050e4c4
Autor:
Abhishek D Garg, Lorenzo eGalluzzi, Lionel eApetoh, Thais eBaert, Raymond B Birge, Jose Manuel Bravo-San Pedro, Karine eBreckpot, David eBrough, Ricardo eChaurio, Mara eCirone, An eCoosemans, Pierre G Coulie, Dirk eDe Ruysscher, Luciana eDini, Peter ede Witte, Aleksandra M Dudek-Peric, Alberto eFaggioni, Jitka eFucikova, Udo S Gaipl, Jakub eGolab, Marie-Lise eGougeon, Michael R Hamblin, Akseli eHemminki, Martin eHerrmann, James W. Hodge, Oliver eKepp, Guido eKroemer, Dmitri V Krysko, Walter G Land, Frank eMadeo, Angelo A. Manfredi, Stephen R. Mattarollo, Christian eMaueroder, Nicolò eMerendino, Gabriele eMulthoff, Thomas ePabst, Jean-Ehrland eRicci, Chiara eRiganti, Erminia eRomano, Nicole eRufo, Mark J. Smyth, Jürgen eSonnemann, Radek eSpisek, John eStagg, Erika eVacchelli, Peter eVandenabeele, Lien eVandenberk, Benoit J Van Den Eynde, Stefaan Willy Van Gool, Francesca eVelotti, Laurence eZitvogel, Patrizia eAgostinis
Publikováno v:
Frontiers in Immunology, Vol 6 (2015)
The immunogenicity of malignant cells has recently been acknowledged as a critical determinant of efficacy in cancer therapy. Thus, besides developing direct immunostimulatory regimens including dendritic cell-based vaccines, checkpoint-blocking ther
Externí odkaz:
https://doaj.org/article/570f706e67a046259f12244a30e66c60
Autor:
Martin eHeil, Walter G Land
Publikováno v:
Frontiers in Plant Science, Vol 5 (2014)
Multicellular organisms suffer injury and serve as hosts for microorganisms. Therefore, they require mechanisms to detect injury and to distinguish the self from the non-self and the harmless non-self (microbial mutualists and commensals) from the de
Externí odkaz:
https://doaj.org/article/ff783e77d72d40e1947d0831db47912e
Autor:
Walter G Land, Konrad eMessmer
Publikováno v:
Frontiers in Immunology, Vol 3 (2012)
Externí odkaz:
https://doaj.org/article/ca24909fb13c4a7d95d9fea595a7665d
Autor:
Walter G. Land
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 143:1864-1865
The first clinical use of the “Munich antilymphocyte globulin” (ALG) at the occasion of the first successful human heart transplantation is briefly described. The cardiac transplantation was carried out by Christiaan Barnard and his team in Cape
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 8 (2017)
Frontiers in Immunology, Vol 8 (2017)
Autor:
Walter G, Land
Publikováno v:
Transplantation reviews (Orlando, Fla.). 26(2)
The innate immune system is an evolutionarily highly conserved first rapid line of host defense against tissue injury and consists of a whole family of mobile and sessile cells such as antigen-presenting cells, innate lymphocytes, neutrophils, and va
Autor:
Walter G, Land
Publikováno v:
Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia. 16(4)
An emerging body of evidence suggests that innate immunity, as the first line of host defence against invading pathogens or their components [pathogen-associated molecular patterns, (PAMPs)], plays also a critical role in acute and chronic allograft
Autor:
Walter G Land
Publikováno v:
Transplantation; Mar2005, Vol. 79 Issue 5, p505-514, 10p
Autor:
Abhishek D Garg, Lorenzo eGalluzzi, Lionel eApetoh, Thais eBaert, Raymond B Birge, Jose Manuel Bravo-San Pedro, Karine eBreckpot, David eBrough, Ricardo eChaurio, Mara eCirone, An eCoosemans, Pierre G Coulie, Dirk eDe Ruysscher, Luciana eDini, Peter ede Witte, Aleksandra M Dudek-Peric, Alberto eFaggioni, Jitka eFucikova, Udo S Gaipl, Jakub eGolab, Marie-Lise eGougeon, Michael R Hamblin, Akseli eHemminki, Martin eHerrmann, James W. Hodge, Oliver eKepp, Guido eKroemer, Dmitri V Krysko, Walter G Land, Frank eMadeo, Angelo A. Manfredi, Stephen R. Mattarollo, Christian eMaueroder, Nicolò eMerendino, Gabriele eMulthoff, Thomas ePabst, Jean-Ehrland eRicci, Chiara eRiganti, Erminia eRomano, Nicole eRufo, Mark J. Smyth, Jürgen eSonnemann, Radek eSpisek, John eStagg, Erika eVacchelli, Peter eVandenabeele, Lien eVandenberk, Benoit J Van Den Eynde, Stefaan Willy Van Gool, Francesca eVelotti, Laurence eZitvogel, Patrizia eAgostinis
Publikováno v:
Frontiers in Immunology, Vol 6 (2015)
Garg, Abhishek D; Galluzzi, Lorenzo; Apetoh, Lionel; Baert, Thais; Birge, Raymond B; Bravo-San Pedro, José Manuel; Breckpot, Karine; Brough, David; Chaurio, Ricardo; Cirone, Mara; Coosemans, An; Coulie, Pierre G; De Ruysscher, Dirk; Dini, Luciana; de Witte, Peter; Dudek-Peric, Aleksandra M; Faggioni, Alberto; Fucikova, Jitka; Gaipl, Udo S; Golab, Jakub; ... (2015). Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death. Frontiers in immunology, 6(588), p. 588. Frontiers Research Foundation 10.3389/fimmu.2015.00588
Frontiers in Immunology
FRONTIERS IN IMMUNOLOGY
University of Manchester-PURE
Frontiers in Immunology, Vol. 6, p. 588 (2015)
Garg, Abhishek D; Galluzzi, Lorenzo; Apetoh, Lionel; Baert, Thais; Birge, Raymond B; Bravo-San Pedro, José Manuel; Breckpot, Karine; Brough, David; Chaurio, Ricardo; Cirone, Mara; Coosemans, An; Coulie, Pierre G; De Ruysscher, Dirk; Dini, Luciana; de Witte, Peter; Dudek-Peric, Aleksandra M; Faggioni, Alberto; Fucikova, Jitka; Gaipl, Udo S; Golab, Jakub; ... (2015). Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death. Frontiers in immunology, 6(588), p. 588. Frontiers Research Foundation 10.3389/fimmu.2015.00588
Frontiers in Immunology
FRONTIERS IN IMMUNOLOGY
University of Manchester-PURE
Frontiers in Immunology, Vol. 6, p. 588 (2015)
The immunogenicity of malignant cells has recently been acknowledged as a critical determinant of efficacy in cancer therapy. Thus, besides developing direct immunostimulatory regimens, including dendritic cell-based vaccines, checkpoint-blocking the